FindTrial
Sign In

Tools for Catching Subclinical Hypothyroidism Early

Study OF thyroid hormones and early Predictive Biomarkers in hypothyroidism. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091766
Enrollment
110
Registered
2025-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Shesharam Patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 13 to 60 years Normal FT3 and FT4 levels TSH between 4.5 10 mIU/L (indicative of subclinical hypothyroidism)

Exclusion criteria

Exclusion criteria: Overt hypothyroidism or hyperthyroidism Current use of thyroid hormone replacement or anti-thyroid drugs History of major systemic illness (e.g., liver disease, renal disease, malignancy) Pregnant or lactating women Patients on corticosteroids or medications affecting thyroid function

Design outcomes

Primary

MeasureTime frame
The ability of serum reverse T3 and FT3/FT4 ratio to predict progression from subclinical hypothyroidism to overt hypothyroidism.Timepoint: At Baseline—

Secondary

MeasureTime frame
Correlation between rT3 & FT3/FT4 ratio with TSH levels & clinical parameters of thyroid dysfunction in SCH patients.Timepoint: At Baseline—

Countries

India

Contacts

Public ContactRaghvendra Singh

UPUMS

dr.raghvendra_singh@yahoo.com09461008561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026